Detalhe da pesquisa
1.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Oncologist;
29(5): e622-e634, 2024 May 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38175669
2.
Differential etiopathogenic features of vulvar squamous cell carcinomas in sub-Saharan Africa and Europe.
Int J Cancer;
152(3): 496-503, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36214794
3.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother;
72(6): 1709-1723, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36625938
4.
Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
Ann Surg Oncol;
30(8): 4657-4668, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36809608
5.
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Future Oncol;
2022 Oct 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36200668
6.
Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019.
Clin Infect Dis;
73(Suppl_5): S454-S464, 2021 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34910166
7.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol;
21(11): 1455-1464, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33152285
8.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast Cancer Res;
22(1): 45, 2020 05 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32404150
9.
Ultrasound Findings of Breast Adenomas.
J Ultrasound Med;
39(11): 2173-2180, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32385901
10.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother;
72(6): 1725-1726, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36809405
11.
ASO Visual Abstract: Nonsentinel Axillary Lymph-Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph-Node-A Predictive Model Proposal.
Ann Surg Oncol;
30(9): 5707-5708, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37405668
12.
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies.
EBioMedicine;
102: 105043, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38447275
13.
Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram.
Cancers (Basel);
15(8)2023 Apr 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37190320
14.
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
J Natl Cancer Inst;
115(3): 332-336, 2023 03 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36576009
15.
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer.
Nat Commun;
14(1): 1157, 2023 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36859416
16.
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer.
Front Oncol;
13: 1151496, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37188177
17.
Quantitative ultrasound image analysis of axillary lymph nodes to differentiate malignancy from reactive benign changes due to COVID-19 vaccination.
Eur J Radiol;
154: 110438, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35820268
18.
Aquaporin-4-Positive Triple-Negative Breast Cancer Presenting with Paraneoplastic Neuromyelitis Optica Spectrum Disorder.
Biomed Hub;
7(1): 11-16, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35223873
19.
Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report.
Front Oncol;
12: 1009352, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36425558
20.
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer.
EBioMedicine;
75: 103801, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34990895